Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Surfeit locus protein 2 (SURF2) is a highly conserved protein encoded by the SURF2 gene in humans, located on chromosome 9q34.2, and is a member of the surfeit gene family[1][4][12]. SURF2 shares a bidirectional promoter with SURF1 and is expressed in a variety of tissues. Functionally, SURF2 interacts with beta-1,4-Gal-T3, uPAR, and WDR20, and acts as a key modulator of nucleolar stress response by binding free 5S ribonucleoprotein particles (5S RNP) but is not directly involved in ribosome assembly[2]. SURF2 buffers 5S RNP activity under basal conditions to prevent unnecessary activation of nucleolar stress, and its expression is implicated in tumorigenesis by influencing p53 activation during cellular stress[2]. Its precise function is not fully elucidated and no drugs or small molecules are documented to target SURF2 directly[2][10]. Additional notes & clarification: - SURF2 is not a classical therapeutic target such as a receptor, enzyme, transporter, or channel. It is best described as a *modulatory scaffold protein* involved in protein–RNA complex interactions[2][10]. - No known drugs, biomarkers, or safety concerns are directly associated with SURF2 as of current knowledge[2][10]. - Molecular and clinical understanding is still evolving, but increased expression and negative correlations with patient survival in certain cancers (e.g., adrenocortical carcinoma) have been documented, suggesting a possible disease relevance, though not yet as a direct drug target[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Surfeit locus protein 2 (SURF2).